Artemether
Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
Product Specifications
CAS Number
71963-77-4
Product Name Alternative
Falcidol | Larither | Malartem | Paluther | SM-224
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Ethanol: 60 mg/mL (201.09 mM) ; DMSO: 60 mg/mL (201.09 mM)
Smiles
C[C@@H]1CC[C@H]2[C@H] ([C@H] (O[C@H]3[C@@]24[C@H]1CC[C@] (O3) (OO4) C) OC) C
Molecular Formula
C16H26O5
Molecular Weight
298.38
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(3R,5aS,6R,8aS,9R,10S,12R,12aR) -decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human RTP3 sgRNA gene knockout kit - Lentiviral human RTP3 sgRNA gene knockout kit (25)
Recombinant Human IgG receptor FcRn large subunit p51 (FCGRT) , partial
Recombinant Human IgG receptor FcRn large subunit p51 (FCGRT) , partial
Recombinant Human IgG receptor FcRn large subunit p51 (FCGRT) , partial
